Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety
Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the
efficacy and safety of a single oral dose of VQW-765 compared to placebo in male and female
participants with performance anxiety.